Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Balthaser Insider Profile
4 Followers
Kevin Balthaser, CFO at Aclaris Therapeutics, holds 23.98K shares in Aclaris Therapeutics (Ticker: ACRS).
Kevin Balthaser has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kevin Balthaser's holdings
Insider Roles
CFO
Roles that Kevin Balthaser holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Balthaser
Kevin Balthaser's Trading History
List of latest transactions for each holding click on a transaction to see Kevin Balthaser's performance on stock
You May Also Like
Kevin Balthaser insider profile FAQ
What is the percentage of profitable transactions made by Kevin Balthaser?
The percentage of profitable transactions made by Kevin Balthaser is ―.
What is the average return per transaction made by Kevin Balthaser?
The average return per transaction made by Kevin Balthaser is ―.
What stocks does Kevin Balthaser hold?
Kevin Balthaser holds: ACRS stocks.
What was Kevin Balthaser’s latest transaction?
Kevin Balthaser latest transaction was an Uninformative Buy of $1.76K.
What was Kevin Balthaser's most profitable transaction?
Kevin Balthaser’s most profitable transaction was an Informative Buy of ACRS stock on September 7, 2023. The return on the trade was -84.10%.
What is Kevin Balthaser's role in Aclaris Therapeutics?
Kevin Balthaser's role in Aclaris Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.